Literature DB >> 23097625

Role of transcriptional corepressor CtBP1 in prostate cancer progression.

Rui Wang1, Irfan A Asangani, Balabhadrapatruni V S K Chakravarthi, Bushra Ateeq, Robert J Lonigro, Qi Cao, Ram-Shankar Mani, Daniel F Camacho, Natalie McGregor, Taibriana E W Schumann, Xiaojun Jing, Radhika Menawat, Scott A Tomlins, Heng Zheng, Arie P Otte, Rohit Mehra, Javed Siddiqui, Saravana M Dhanasekaran, Mukesh K Nyati, Kenneth J Pienta, Nallasivam Palanisamy, Lakshmi P Kunju, Mark A Rubin, Arul M Chinnaiyan, Sooryanarayana Varambally.   

Abstract

Transcriptional repressors and corepressors play a critical role in cellular homeostasis and are frequently altered in cancer. C-terminal binding protein 1 (CtBP1), a transcriptional corepressor that regulates the expression of tumor suppressors and genes involved in cell death, is known to play a role in multiple cancers. In this study, we observed the overexpression and mislocalization of CtBP1 in metastatic prostate cancer and demonstrated the functional significance of CtBP1 in prostate cancer progression. Transient and stable knockdown of CtBP1 in prostate cancer cells inhibited their proliferation and invasion. Expression profiling studies of prostate cancer cell lines revealed that multiple tumor suppressor genes are repressed by CtBP1. Furthermore, our studies indicate a role for CtBP1 in conferring radiation resistance to prostate cancer cell lines. In vivo studies using chicken chorioallantoic membrane assay, xenograft studies, and murine metastasis models suggested a role for CtBP1 in prostate tumor growth and metastasis. Taken together, our studies demonstrated that dysregulated expression of CtBP1 plays an important role in prostate cancer progression and may serve as a viable therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23097625      PMCID: PMC3479836          DOI: 10.1593/neo.121192

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  36 in total

1.  TaqMan-based quantification of invasive cells in the chick embryo metastasis assay.

Authors:  Edward Htun van der Horst; Jörg H Leupold; Rainer Schubbert; Axel Ullrich; Heike Allgayer
Journal:  Biotechniques       Date:  2004-12       Impact factor: 1.993

2.  Integrative molecular concept modeling of prostate cancer progression.

Authors:  Scott A Tomlins; Rohit Mehra; Daniel R Rhodes; Xuhong Cao; Lei Wang; Saravana M Dhanasekaran; Shanker Kalyana-Sundaram; John T Wei; Mark A Rubin; Kenneth J Pienta; Rajal B Shah; Arul M Chinnaiyan
Journal:  Nat Genet       Date:  2006-12-17       Impact factor: 38.330

3.  Role of the PLDLS-binding cleft region of CtBP1 in recruitment of core and auxiliary components of the corepressor complex.

Authors:  M Kuppuswamy; S Vijayalingam; Ling-Jun Zhao; Yun Zhou; T Subramanian; Jan Ryerse; G Chinnadurai
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

4.  Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer.

Authors:  Zhimin Tong; Ajaikumar B Kunnumakkara; Huamin Wang; Yoichi Matsuo; Parmeswaran Diagaradjane; Kuzhuvelil B Harikumar; Vijaya Ramachandran; Bokyung Sung; Arup Chakraborty; Robert S Bresalier; Craig Logsdon; Bharat B Aggarwal; Sunil Krishnan; Sushovan Guha
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

5.  The carboxy-terminal region of adenovirus E1A activates transcription through targeting of a C-terminal binding protein-histone deacetylase complex.

Authors:  A Sundqvist; K Sollerbrant; C Svensson
Journal:  FEBS Lett       Date:  1998-06-12       Impact factor: 4.124

6.  Homeodomain-interacting protein kinase-2 mediates CtBP phosphorylation and degradation in UV-triggered apoptosis.

Authors:  Qinghong Zhang; Amanda Nottke; Richard H Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-11       Impact factor: 11.205

7.  Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation.

Authors:  U Schaeper; J M Boyd; S Verma; E Uhlmann; T Subramanian; G Chinnadurai
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

8.  Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP.

Authors:  Qinghong Zhang; Yasuhiro Yoshimatsu; Jeffrey Hildebrand; Steven M Frisch; Richard H Goodman
Journal:  Cell       Date:  2003-10-17       Impact factor: 41.582

9.  C-Terminal binding protein is a transcriptional repressor that interacts with a specific class of vertebrate Polycomb proteins.

Authors:  R G Sewalt; M J Gunster; J van der Vlag; D P Satijn; A P Otte
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

10.  Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines.

Authors:  Danny F Dukers; Joost C van Galen; Cindy Giroth; Patty Jansen; Richard G A B Sewalt; Arie P Otte; Hanneke C Kluin-Nelemans; Chris J L M Meijer; Frank M Raaphorst
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

View more
  39 in total

1.  Crystal structures of human CtBP in complex with substrate MTOB reveal active site features useful for inhibitor design.

Authors:  Brendan J Hilbert; Steven R Grossman; Celia A Schiffer; William E Royer
Journal:  FEBS Lett       Date:  2014-03-19       Impact factor: 4.124

2.  Assembly of human C-terminal binding protein (CtBP) into tetramers.

Authors:  Andrew G Bellesis; Anne M Jecrois; Janelle A Hayes; Celia A Schiffer; William E Royer
Journal:  J Biol Chem       Date:  2018-04-26       Impact factor: 5.157

3.  Silencing of CtBP1 suppresses the migration in human glioma cells.

Authors:  Chengjin Zhao; Yifen Shen; Xuelei Tao; Jian Xu; Junjie Lu; Chao Liu; Zhiwei Xu; Qing Tang; Tao Tao; Xiubing Zhang
Journal:  J Mol Histol       Date:  2016-05-09       Impact factor: 2.611

4.  Cancer subclonal genetic architecture as a key to personalized medicine.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

5.  Structure-guided design of a high affinity inhibitor to human CtBP.

Authors:  Brendan J Hilbert; Benjamin L Morris; Keith C Ellis; Janet L Paulsen; Celia A Schiffer; Steven R Grossman; William E Royer
Journal:  ACS Chem Biol       Date:  2015-01-30       Impact factor: 5.100

6.  Prostate tumor growth is impaired by CtBP1 depletion in high-fat diet-fed mice.

Authors:  Cristian P Moiola; Paola De Luca; Florencia Zalazar; Javier Cotignola; Santiago A Rodríguez-Seguí; Kevin Gardner; Roberto Meiss; Pablo Vallecorsa; Omar Pignataro; Osvaldo Mazza; Elba S Vazquez; Adriana De Siervi
Journal:  Clin Cancer Res       Date:  2014-05-19       Impact factor: 12.531

Review 7.  Transcription factors, transcriptional coregulators, and epigenetic modulation in the control of pulmonary vascular cell phenotype: therapeutic implications for pulmonary hypertension (2015 Grover Conference series).

Authors:  Soni S Pullamsetti; Frédéric Perros; Prakash Chelladurai; Jason Yuan; Kurt Stenmark
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

Review 8.  Long Noncoding RNA and Cancer: A New Paradigm.

Authors:  Arunoday Bhan; Milad Soleimani; Subhrangsu S Mandal
Journal:  Cancer Res       Date:  2017-07-12       Impact factor: 12.701

9.  Hierarchical Feature Selection Incorporating Known and Novel Biological Information: Identifying Genomic Features Related to Prostate Cancer Recurrence.

Authors:  Yize Zhao; Matthias Chung; Brent A Johnson; Carlos S Moreno; Qi Long
Journal:  J Am Stat Assoc       Date:  2017-01-04       Impact factor: 5.033

10.  Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.

Authors:  Min Li; Suzette Riddle; Hui Zhang; Angelo D'Alessandro; Amanda Flockton; Natalie J Serkova; Kirk C Hansen; Radu Moldovan; B Alexandre McKeon; Maria Frid; Sushil Kumar; Hong Li; Hongbing Liu; Angela Caánovas; Juan F Medrano; Milton G Thomas; Dijana Iloska; Lydie Plecitá-Hlavatá; Petr Ježek; Soni Pullamsetti; Mehdi A Fini; Karim C El Kasmi; QingHong Zhang; Kurt R Stenmark
Journal:  Circulation       Date:  2016-08-25       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.